These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Peripheral polyneuropathy during treatment with alpha-2 interferon. Cudillo L; Cantonetti M; Venditti A; Lentini R; Rossini PM; Caramia M; Masi M; Papa G Haematologica; 1990; 75(5):485-6. PubMed ID: 1965833 [No Abstract] [Full Text] [Related]
3. [Interferon alpha in the treatment of chronic myeloid leukemia]. Tóthová E; Fricová M; Stecová N; Svorcová E; Surová M; Kafková A; Guman T; Mudronová B Vnitr Lek; 1996 May; 42(5):327-30. PubMed ID: 8768291 [TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic myelogenous leukemia with interferon alfa-2c: response rate and toxicity in a phase II multicenter study. The Austrian Biological Response Modifier (BRM) Study Group. Thaler J; Gastl G; Fluckinger T; Niederwieser D; Huber H; Seewann H; Silly H; Lang A; Abbrederis C; Gadner H Semin Hematol; 1993 Jul; 30(3 Suppl 3):17-9. PubMed ID: 8235697 [No Abstract] [Full Text] [Related]
6. Interferon alfa has become a standard in the treatment of chronic myelogenous leukemia. Freund M; Huber C Semin Hematol; 1993 Jul; 30(3 Suppl 3):1-5. PubMed ID: 8235694 [No Abstract] [Full Text] [Related]
7. High response rate using recombinant interferon-alpha in patients with newly diagnosed chronic myeloid leukemia. Mahon FX; Fabères C; Montastruc M; Si-Mour S; Boiron JM; Marit G; Bilhou-Nabera C; Cony-Makhoul P; Pigneux A; Bernard P; Broustet A; Reiffers J Bone Marrow Transplant; 1996 May; 17 Suppl 3():S33-7. PubMed ID: 8769698 [TBL] [Abstract][Full Text] [Related]
8. Pregnancy occurring during complete cytogenetic response after interferon therapy in chronic myeloid leukaemia. Longree L; Pautier P; Guilhot F; Brice P Nouv Rev Fr Hematol (1978); 1995; 37(4):249-50. PubMed ID: 8904206 [TBL] [Abstract][Full Text] [Related]
13. [Molecular biology follow-up of interferon therapy in patients with chronic myeloid leukemia]. Iványi JL; Marton E; Kereskai L; Kiss Z; Pajor L Orv Hetil; 2000 Nov; 141(47):2527-33. PubMed ID: 11143285 [TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha and interleukin-2 as treatment for leukemia relapse after allogeneic bone marrow transplantation. Giralt S; O'Brien S; Talpaz M; Van Besien K; Chan KW; Rondón G; Andersson B; Mehra R; Khouri I; Estey E Cytokines Mol Ther; 1995 Jun; 1(2):115-22. PubMed ID: 9384668 [TBL] [Abstract][Full Text] [Related]
15. Expression of c-fos correlates with IFN-alpha responsiveness in Philadelphia chromosome positive chronic myelogenous leukemia. Eibl B; Greiter E; Grünewald K; Gastl G; Weyrer K; Thaler J; Aulitzky W; Herrmann F; Rapp U; Huber C Cytokines Mol Ther; 1995 Mar; 1(1):29-38. PubMed ID: 9384661 [TBL] [Abstract][Full Text] [Related]
16. [A modern therapeutic strategy in Ph-positive chronic myeloleukemia]. Khoroshko ND; Turkina AG; Zhuravlev VS; Sokolova MA; Mikhaĭlova IN; Zakharova AV; Domracheva EV; Semenova EA Ter Arkh; 1996; 68(7):22-7. PubMed ID: 8928067 [TBL] [Abstract][Full Text] [Related]
17. Nephrotic syndrome associated with alpha interferon therapy in chronic myeloid leukemia. Budak-Alpdoğan T; Lawrence RA; Bayik M; Akoğlu E Clin Nephrol; 1997 Jul; 48(1):59-60. PubMed ID: 9247783 [No Abstract] [Full Text] [Related]
18. A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia. Meloni G; Russo D; Baccarani M; Testoni N; Martinelli G; Fanin R; Zuffa E; Rosti G; Alimena G; Saglio G; Mandelli F; Tura S Haematologica; 1999 Aug; 84(8):707-15. PubMed ID: 10457406 [TBL] [Abstract][Full Text] [Related]
19. Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia. Westermann J; Kopp J; van Lessen A; Hecker AC; Baskaynak G; le Coutre P; Döhner K; Döhner H; Dörken B; Pezzutto A Br J Haematol; 2007 May; 137(4):297-306. PubMed ID: 17408402 [TBL] [Abstract][Full Text] [Related]
20. [Interferon-alpha in the treatment of patients with chronic myeloid leukemia]. Faber E; Jarosová M; Divoký V; Luhový M; Komenda S; Sulovská I; Hubácek J; Slezák P; Papajik T; Raida L; Heczko M; Indrák K Vnitr Lek; 1997 Jan; 43(1):13-7. PubMed ID: 9221559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]